Literature DB >> 26045765

Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29.

Xiaofeng Yu1, Zhenzhen Du1, Xuhong Sun2, Chuanqin Shi1, Huaixiang Zhang1, Tao Hu1.   

Abstract

The Tn antigen, which arises from mutation in the Cosmc gene is one of the most common tumor associated carbohydrate antigens. Cosmc resides in X24 encoded by a single gene and functions as a specific molecular chaperone for T-synthase. While the Tn antigen cannot be detected in normal cells, Cosmc mutations inactivate T-synthase and consequently result in Tn antigen expression within certain cancers. In addition to this Cosmc mutation-induced expression, the Tn antigen is also expressed in such cell lines as Jurkat T, LSC and LS174T. Whether the Cosmc mutation is present in the colon cancer cell line HT-29 is still unclear. Here, we isolate HT-29-Tn+ cells from HT-29 cells derived from a female colon cancer patient. These HT-29-Tn+ cells show a loss of the Cosmc gene coding sequence (CDS) leading to an absence of T-synthase activity and Tn antigen expression. Additionally, almost no methylation of Cosmc CpG islands was detected in HT-29-Tn+ as well as in HT-29-Tn- and Tn- tumor cells from male patients. In contrast, the methylation frequency of CpG island of Cosmc in normal female cells was ~50%. Only one active allele of Cosmc existed in HT-29-Tn+ and HT-29-Tn- cells as based upon detection of SNP sites. These results indicate that Tn antigens expression and T-synthase inactivity in HT-29-Tn+ cells can be related to the absence of CDS in Cosmc active alleles, while an inactive allele deletion of Cosmc in HT-29 cells has no influence on Cosmc function.

Entities:  

Keywords:  Cosmc; CpG methylation; T-synthase; Tn antigen; colon cancer

Mesh:

Substances:

Year:  2015        PMID: 26045765      PMCID: PMC4440074     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  44 in total

Review 1.  Immunoreactive T and Tn antigens in malignancy: role in carcinoma diagnosis, prognosis, and immunotherapy.

Authors:  P R Desai
Journal:  Transfus Med Rev       Date:  2000-10

2.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase.

Authors:  Tongzhong Ju; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-03       Impact factor: 11.205

3.  Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44.

Authors:  R Singh; B J Campbell; L G Yu; D G Fernig; J D Milton; R A Goodlad; A J FitzGerald; J M Rhodes
Journal:  Glycobiology       Date:  2001-07       Impact factor: 4.313

4.  Association between functional polymorphism in EGF gene and malignant melanoma.

Authors:  Majid Shahbazi; Vera Pravica; Najma Nasreen; Hana Fakhoury; Anthony A Fryer; Richard C Strange; Peter E Hutchinson; Joy E Osborne; John T Lear; Andrew G Smith; Ian V Hutchinson
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

5.  Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis.

Authors:  Akira Konno; Yutaka Hoshino; Shinya Terashima; Ryoichi Motoki; Takanori Kawaguchi
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 6.  Tn-syndrome.

Authors:  E G Berger
Journal:  Biochim Biophys Acta       Date:  1999-10-08

7.  The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing.

Authors:  J W Homeister; A D Thall; B Petryniak; P Malý; C E Rogers; P L Smith; R J Kelly; K M Gersten; S W Askari; G Cheng; G Smithson; R M Marks; A K Misra; O Hindsgaul; U H von Andrian; J B Lowe
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

8.  Cloning and expression of human core 1 beta1,3-galactosyltransferase.

Authors:  Tongzhong Ju; Kevin Brewer; Anil D'Souza; Richard D Cummings; William M Canfield
Journal:  J Biol Chem       Date:  2001-10-24       Impact factor: 5.157

Review 9.  Searching for genetic determinants in the new millennium.

Authors:  N J Risch
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

10.  Lectin histochemistry of resected adenocarcinoma of the lung: helix pomatia agglutinin binding is an independent prognostic factor.

Authors:  Eckart Laack; Haleh Nikbakht; Anja Peters; Christian Kugler; Yvonne Jasiewicz; Lutz Edler; Dieter Kurt Hossfeld; Udo Schumacher
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

View more
  11 in total

1.  "Stuck on sugars - how carbohydrates regulate cell adhesion, recognition, and signaling".

Authors:  Richard D Cummings
Journal:  Glycoconj J       Date:  2019-07-02       Impact factor: 2.916

Review 2.  Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).

Authors:  Ryan L Hanson; Michael A Hollingsworth
Journal:  Biomolecules       Date:  2016-07-30

3.  Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.

Authors:  Xiaodong Sun; Tongzhong Ju; Richard D Cummings
Journal:  BMC Cancer       Date:  2018-08-16       Impact factor: 4.430

4.  Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation.

Authors:  Zhe Liu; Jian Liu; Xichen Dong; Xin Hu; Yuliang Jiang; Lina Li; Tan Du; Lei Yang; Tao Wen; Guangyu An; Guosheng Feng
Journal:  J Cell Mol Med       Date:  2019-01-13       Impact factor: 5.310

5.  Demethylation of the Cosmc Promoter Alleviates the Progression of Breast Cancer Through Downregulation of the Tn and Sialyl-Tn Antigens.

Authors:  Feng Xu; Dong Wang; JianXiu Cui; Jie Li; Hongchuan Jiang
Journal:  Cancer Manag Res       Date:  2020-02-11       Impact factor: 3.989

6.  Cosmc transfection decreases malignant behavior of Tn+ cells and enhances sensitivity to apoptosis when induced by Apo2L/TRAIL via alteration of O-glycan structure.

Authors:  Ruisong Ding; Xingyou Hu; Wen Hu; Zhenzhen Du; Panpan Huang; Mengyang Wang; Jiaoyue Sheng; Yanchao Ma; Ailing Wang; Xiying Luan; Menghua Dong; Qizhi Cao; Yanfen Zou; Tao Hu
Journal:  Aging (Albany NY)       Date:  2021-10-13       Impact factor: 5.682

7.  Expression of SAMHD1 and its mutation on prognosis of colon cancer.

Authors:  Zhou Zhang; Ping Li; Ping Sun
Journal:  Oncol Lett       Date:  2022-07-08       Impact factor: 3.111

8.  The cytokine-cosmc signaling axis upregulates the tumor-associated carbohydrate antigen Tn.

Authors:  Chia-Wen Ho; Chi-Yu Lin; Yi-Wei Liaw; Hsiao-Ling Chiang; Yu-Tang Chin; Rui-Lan Huang; Hung-Cheng Lai; Yaw-Wen Hsu; Po-Jan Kuo; Chiao-En Chen; Hung-Yan Lin; Jacqueline Whang-Peng; Shin Nieh; Earl Fu; Leroy F Liu; Jaulang Hwang
Journal:  Oncotarget       Date:  2016-09-20

9.  Knockdown of C1GalT1 inhibits radioresistance of human esophageal cancer cells through modifying β1-integrin glycosylation.

Authors:  Chuanyi Zhang; Xinzhou Deng; Li Qiu; Feng Peng; Shanshan Geng; Li Shen; Zhiguo Luo
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

10.  Overexpression of Cosmc suppresses cell migration and invasion in different subtypes of breast cancer cells via Tn and T glycans.

Authors:  Jun Liu; Feng Xu; Jie Li; Hongchuan Jiang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.